These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 25525851

  • 1. Pleural effusion in a patient with metastatic gastrointestinal stromal tumor treated with imatinib: case report.
    Bongiovanni A, Ricci M, Riva N, Calpona S, Oboldi D, Pieri F, Cavaliere D, Mercatali L, Liverani C, La Manna F, De Vita A, Foca F, Gunelli E, Amadori D, Ibrahim T.
    Future Oncol; 2014 Dec; 10(15):2423-7. PubMed ID: 25525851
    [Abstract] [Full Text] [Related]

  • 2. Radiologic assessment of earliest, best, and plateau response of gastrointestinal stromal tumors to neoadjuvant imatinib prior to successful surgical resection.
    Tirumani SH, Shinagare AB, Jagannathan JP, Krajewski KM, Ramaiya NH, Raut CP.
    Eur J Surg Oncol; 2014 Apr; 40(4):420-8. PubMed ID: 24238762
    [Abstract] [Full Text] [Related]

  • 3. Long-term follow-up outcome of imatinib mesylate treatment for recurrent and unresectable gastrointestinal stromal tumors.
    Saito S, Nakata K, Kajiura S, Ando T, Hosokawa A, Sugiyama T.
    Digestion; 2013 Apr; 87(1):47-52. PubMed ID: 23343969
    [Abstract] [Full Text] [Related]

  • 4. Complete pathological response in advanced extra-gastrointestinal stromal tumor after imatinib mesylate therapy: a case report.
    Rediti M, Pellegrini E, Molinara E, Cerullo C, Fonte C, Lunghi A, Iori A, Neri B.
    Anticancer Res; 2014 Feb; 34(2):905-7. PubMed ID: 24511030
    [Abstract] [Full Text] [Related]

  • 5. Fluid retention associated with imatinib treatment in patients with gastrointestinal stromal tumor: quantitative radiologic assessment and implications for management.
    Kim KW, Shinagare AB, Krajewski KM, Pyo J, Tirumani SH, Jagannathan JP, Ramaiya NH.
    Korean J Radiol; 2015 Feb; 16(2):304-13. PubMed ID: 25741192
    [Abstract] [Full Text] [Related]

  • 6. Gastrointestinal stromal tumor with metastases in an adult woman treated with imatinib mesylate: MDCT findings.
    Busalacchi PJ, de la Calle MA, Torroba A, Del Río ST.
    AJR Am J Roentgenol; 2005 Mar; 184(3 Suppl):S58-61. PubMed ID: 15728023
    [No Abstract] [Full Text] [Related]

  • 7. [Molecular and histologic characteristics of secondary imatinib-resistant gastrointestinal stromal tumors].
    Zheng S, Jia J, Pan YL, Tao DY, Lu HS.
    Zhonghua Bing Li Xue Za Zhi; 2013 Jan; 42(1):42-3. PubMed ID: 23611272
    [No Abstract] [Full Text] [Related]

  • 8. Successful treatment with sunitinib in a young patient with metastatic gastrointestinal stromal tumor after failure on adjuvant imatinib.
    Kapoor R, Khosla D, Kumar P, Kumar N, Bera A.
    J Cancer Res Ther; 2011 Jan; 7(4):491-3. PubMed ID: 22269418
    [No Abstract] [Full Text] [Related]

  • 9. CT scan is not everything in the evaluation of a patient with gastrointestinal tumors (GIST) under imatinib therapy.
    Wang CM, Fu H, Zhao GF, Wang J, Shi YQ.
    Pathol Oncol Res; 2012 Oct; 18(4):1095-7. PubMed ID: 21927980
    [No Abstract] [Full Text] [Related]

  • 10. [18F-FDG PET/CT in response evaluation of gastrointestinal stromal tumours treated with imatinib].
    Banzo I, Quirce R, Martínez-Rodríguez I, Jiménez-Bonilla JF, Sainz-Esteban A, Barragán J, Portilla-Quattrociocchi H, Carril JM.
    Rev Esp Med Nucl; 2008 Oct; 27(3):168-75. PubMed ID: 18570858
    [Abstract] [Full Text] [Related]

  • 11. ACRIN 6665/RTOG 0132 phase II trial of neoadjuvant imatinib mesylate for operable malignant gastrointestinal stromal tumor: monitoring with 18F-FDG PET and correlation with genotype and GLUT4 expression.
    Van den Abbeele AD, Gatsonis C, de Vries DJ, Melenevsky Y, Szot-Barnes A, Yap JT, Godwin AK, Rink L, Huang M, Blevins M, Sicks J, Eisenberg B, Siegel BA.
    J Nucl Med; 2012 Apr; 53(4):567-74. PubMed ID: 22381410
    [Abstract] [Full Text] [Related]

  • 12. Imatinib plasma monitoring-guided dose modification for managing imatinib-related toxicities in gastrointestinal stromal tumor patients.
    Yoon S, Ryu MH, Yoo C, Beck MY, Ryoo BY, Kang YK.
    J Korean Med Sci; 2013 Aug; 28(8):1248-52. PubMed ID: 23960456
    [Abstract] [Full Text] [Related]

  • 13. Clonal evolution of resistance to imatinib in patients with metastatic gastrointestinal stromal tumors.
    Desai J, Shankar S, Heinrich MC, Fletcher JA, Fletcher CD, Manola J, Morgan JA, Corless CL, George S, Tuncali K, Silverman SG, Van den Abbeele AD, van Sonnenberg E, Demetri GD.
    Clin Cancer Res; 2007 Sep 15; 13(18 Pt 1):5398-405. PubMed ID: 17875769
    [Abstract] [Full Text] [Related]

  • 14. [Utility of FDG-PET for early evaluation of efficiency of imatinib mesylate (Glivec) in the treatment of gastrointestinal stromal tumors].
    García-González J, Sánchez Salmón A, Areses Manrique C, León Mateos L, Barandela Salgado J, López López R.
    Rev Esp Med Nucl; 2007 Sep 15; 26(2):100-2. PubMed ID: 17386236
    [Abstract] [Full Text] [Related]

  • 15. Haemoperitoneum as an indicator of GIST.
    de Juan Ferré A, Gutiérrez L, Garicano F, Malaxetxebarria S, Fernández F.
    Anticancer Drugs; 2012 Jun 15; 23 Suppl():S10-2. PubMed ID: 22739665
    [Abstract] [Full Text] [Related]

  • 16. Advanced or metastatic gastrointestinal stromal tumors: systemic treatment options.
    Caram MV, Schuetze SM.
    J Surg Oncol; 2011 Dec 15; 104(8):888-95. PubMed ID: 22069173
    [Abstract] [Full Text] [Related]

  • 17. [A case of rectal gastrointestinal stromal tumor in an elderly patient who was successfully treated with imatinib mesylate with no significant adverse events].
    Gomi K, Mihara M, Abe M, Ikeda Y, Shimada K, Maruyama K, Kajikawa S, Shirota H.
    Gan To Kagaku Ryoho; 2014 Jan 15; 41(1):103-6. PubMed ID: 24423962
    [Abstract] [Full Text] [Related]

  • 18. Approval summary: imatinib mesylate in the treatment of metastatic and/or unresectable malignant gastrointestinal stromal tumors.
    Dagher R, Cohen M, Williams G, Rothmann M, Gobburu J, Robbie G, Rahman A, Chen G, Staten A, Griebel D, Pazdur R.
    Clin Cancer Res; 2002 Oct 15; 8(10):3034-8. PubMed ID: 12374669
    [Abstract] [Full Text] [Related]

  • 19. [Clinical experience of imatinib mesylate for metastatic or recurrent gastrointestinal stromal tumor].
    Toyokawa T, Yamashita Y, Yamamoto A, Shimizu S, Inoue T, Kanazawa A, Tsukamoto T, Ikehara T, Nishiguchi Y.
    Gan To Kagaku Ryoho; 2014 Jan 15; 41(1):55-8. PubMed ID: 24423952
    [Abstract] [Full Text] [Related]

  • 20. Value of pharmacokinetic studies for patients with gastrointestinal stromal tumors.
    De Giorgi U.
    Future Oncol; 2013 Nov 15; 9(11):1675-7. PubMed ID: 23862700
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.